Chemical formula: C₁₁H₁₈N₂O₃  Molecular mass: 226.272 g/mol  PubChem compound: 2164

Active ingredient description

Amobarbital is a barbiturate derivative with hypnotic and sedative properties (but not antianxiety), used for the induction of sedation during procedures, short-term management of insomnia, and acute management of refractory tonic-clonic seizures.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N05CA02 Amobarbital N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CA Barbiturates, plain
Discover more medicines within N05CA02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
AMYTAL SODIUM Powder for solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 57-43-2
DrugBank Drug: DB01351
KEGG Drug: D00555
PubChem Compound: 2164
RxNorm Ingredient: 719
SNOMED-CT Concept: 372831009
Amobarbital (substance)
UNII Identifier: GWH6IJ239E


Amobarbital is an active ingredient of these brands:

Japan (JP)

United Kingdom (UK)

  • (combination) TUINAL as AMOBARBITAL SODIUM

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.